Carbidopa and Levodopa Tablets
» Carbidopa and Levodopa Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amounts of carbidopa (C10H14N2O4) and of levodopa (C9H11NO4).
Packaging and storage—
Preserve in well-closed, light-resistant containers.
') + '&img=../../images/v35300/cas-38821-49-7.gif',600,500);)
') + '&img=../../images/v35300/cas-59-92-7.gif',600,500);)
Identification—
Transfer a portion of powdered Tablets, equivalent to about 10 mg of carbidopa, to a 100-mL volumetric flask containing about 50 mL of 0.05 N hydrochloric acid. Agitate for 20 minutes, add methanol to volume, mix, and filter or centrifuge. Separately prepare 2 Standard solutions containing 0.1 mg per mL of USP Carbidopa RS and USP Levodopa RS, respectively, in a solvent prepared by mixing equal volumes of 0.05 N hydrochloric acid and methanol. Apply 20 µL of the test solution and 20 µL of each Standard solution at separate points to a thin-layer chromatographic plate (see Chromatography 
621
) coated with a 0.25-mm layer of chromatographic silica gel. Develop the chromatogram using a solvent system consisting of a mixture of acetone, chloroform, n-butanol, glacial acetic acid, and water (60:40:40:40:35) until the solvent front has moved about 15 cm. Air-dry, spray uniformly with about 0.5 mL of ninhydrin reagent (prepared by dissolving 0.3 g of ninhydrin in 100 mL of n-butanol acidified with 3 mL of glacial acetic acid), and heat at 105
for about 10 minutes: the solution under test exhibits two spots (reddish brown for levodopa and yellow-orange for carbidopa) having RF values that correspond to those exhibited by the Standard solutions.
621) coated with a 0.25-mm layer of chromatographic silica gel. Develop the chromatogram using a solvent system consisting of a mixture of acetone, chloroform, n-butanol, glacial acetic acid, and water (60:40:40:40:35) until the solvent front has moved about 15 cm. Air-dry, spray uniformly with about 0.5 mL of ninhydrin reagent (prepared by dissolving 0.3 g of ninhydrin in 100 mL of n-butanol acidified with 3 mL of glacial acetic acid), and heat at 105 for about 10 minutes: the solution under test exhibits two spots (reddish brown for levodopa and yellow-orange for carbidopa) having RF values that correspond to those exhibited by the Standard solutions.
Dissolution 711—
711—
Medium:
0.1 N hydrochloric acid; 750 mL.
Apparatus 1:
50 rpm.
Time:
30 minutes.
Procedure—
Determine the amounts of carbidopa and levodopa in solution in filtered portions of the solution under test, in comparison with a Standard solution having known concentrations of USP Carbidopa RS and USP Levodopa RS in the same medium, as directed for Procedure in the Assay.
Tolerances—
Not less than 80% (Q) of the labeled amounts of carbidopa (C10H14N2O4) and levodopa (C9H11NO4) is dissolved in 30 minutes.
Uniformity of dosage units 905:
meet the requirements.
905:
meet the requirements.
Assay—
Sodium 1-decanesulfonate solution—
Dissolve 0.24 g of sodium 1-decanesulfonate in 1 L of water.
Mobile phase—
Mix 11.04 g of monobasic sodium phosphate and 950 mL of water in a beaker. Add 1.3 mL of Sodium 1-decanesulfonate solution, and adjust with phosphoric acid to a pH of 2.8. Transfer to a 1-L volumetric flask, dilute with water to volume, and pass through a membrane filter.
Standard preparation—
Transfer about 50 mg of USP Levodopa RS, accurately weighed, to a 100-mL volumetric flask. Add an accurately weighed quantity of USP Carbidopa RS, which is in a ratio with USP Levodopa RS that corresponds with the ratio of carbidopa to levodopa in the Tablets. Add 10 mL of 0.1 N phosphoric acid. Warm gently to dissolve the standards. Dilute with water to volume, and mix.
Assay preparation—
Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 50 mg of levodopa, to a 100-mL volumetric flask, add 10 mL of 0.1 N phosphoric acid, dilute with water to volume, and mix.
Chromatographic system (see Chromatography 621)—
The liquid chromatograph is equipped with a 280-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate, about 2 mL per minute, is adjusted until the retention times for levodopa and carbidopa are about 4 minutes and 11 minutes, respectively. Chromatograph five replicate injections of the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation is not more than 2.0%; and the resolution factor between levodopa and carbidopa is not less than 6.
621)—
The liquid chromatograph is equipped with a 280-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate, about 2 mL per minute, is adjusted until the retention times for levodopa and carbidopa are about 4 minutes and 11 minutes, respectively. Chromatograph five replicate injections of the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation is not more than 2.0%; and the resolution factor between levodopa and carbidopa is not less than 6.
Procedure—
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph by means of a suitable microsyringe or sampling valve, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of carbidopa (C10H14N2O4) in the portion of Tablets taken by the formula:
(100C)(rU / rS)
in which C is the concentration, in mg per mL, of USP Carbidopa RS in the Standard preparation; and rU and rS are the responses of the carbidopa peak obtained from the Assay preparation and the Standard preparation, respectively. Calculate the quantity, in mg, of levodopa (C9H11NO4) by the same formula, reading the terms to refer to levodopa instead of carbidopa.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
|---|---|---|
| Monograph | Ravi Ravichandran, Ph.D.
Principal Scientific Liaison 1-301-816-8330 |
(SM42010) Monographs - Small Molecules 4 |
| Reference Standards | RS Technical Services 1-301-816-8129 rstech@usp.org |
|
| 711 |
Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison 1-301-816-8106 |
(GCDF2010) General Chapters - Dosage Forms |
USP35–NF30 Page 2488
Pharmacopeial Forum: Volume No. 29(3) Page 615